Get Premium to unlock powerful stock data
NAS:CYAD (Belgium)   Healthcare » Biotechnology
Celyad Oncology logo

Celyad Oncology $ 3.81 -0.03 (-0.78%)

Volume:
2,382
Avg Vol (1m):
1,520,484
Market Cap $:
86.07 Mil
Enterprise Value $:
85.44 Mil
PE Ratio:
At Loss
PB Ratio:
2.19
Warning! GuruFocus has detected 5 Severe warning signs with CYAD. Click here to check it out.
EMBED
10Y: -% Above Low: +NaN% Below High: NaN%
Peers

Celyad Oncology Stock Institutional Ownership and Insider Ownership -

22.59
(Mil)
Shares Outstanding
0.34%
0.06 (Mil)
Institutional Ownership
0%
0.00 (Mil)
Insider Ownership
0.00%
0 (Mil)
Float Percentage of TSO

Short Interest History (%)

Due to a license agreement change with our data vendor, Short Interest related data is no longer available on GuruFocus’ website, except for certain Australian stocks.

Institutional Ownership History (%)

This the Institutional Ownership History of Celyad Oncology. Peter Lynch prefers to buy companies with low institutional ownership.
EMBED

Insider ownership (%)

This is the historical insider ownership of Celyad Oncology. It is usually better to buy companies with large insider ownership. The company insiders' interest are more aligned with external shareholders in this case.

Top Direct Holders

Top Fund Holders